share_log

艾迪药业董事会关于评估机构独立性、评估假设前提合理性、评估方法与评估目的相关性及评估定价公允性的说明

Explanation of Jiangsu Aidea Pharmaceutical's board of directors on the evaluation of the independence of the institutions, the reasonableness of the evaluation assumptions, the relevance of the evaluation methods and evaluation objectives, and the fairness of the evaluation pricing.

SZSI ·  Jun 26

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.